Warfarin-associated intraventricular hemorrhage

Neurological Research

Volumn 29, Issue 7, 2007, Pages 661-663

  Zubkov, Alexander ^a   Claassen, Daniel O ^a   Rabinstein, Alejandro A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Anticoagulation induced hemorrhage; Intraventricular hemorrhage; Mortality; Warfarin

Indexed keywords

WARFARIN;

AGED; ARTICLE; BRAIN HEMORRHAGE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HEART VALVE PROSTHESIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MEDICAL RECORD; MORTALITY; PROGNOSIS; THALAMUS MIDLINE NUCLEUS;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BRAIN; CEREBRAL ARTERIES; CEREBRAL HEMORRHAGE; CHOROID PLEXUS; FEMALE; HOSPITAL MORTALITY; HUMANS; LATERAL VENTRICLES; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; WARFARIN;

EID: 36048995377     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164107X247227     Document Type: Article

References (19)

1. Franke CL, de Jonge J, van Swieten JC, et al. Intracerebral hematomas during anticoagulant treatment. Stroke 1990; 21: 726-730
2. Rosand J, Eckman MH, Knudsen KA, et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004; 164: 880-884
3. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. Arch Intern Med 1996; 156: 409-416
4. Sjoblom L, Hardemark HG, Lindgren A, et al. Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: A Swedish multicenter study. Stroke 2001; 32: 2567-2574
5. Tuhrim S, Horowitz DR, Sacher M, et al. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 1999; 27: 617-621
6. Radberg J, Olsson J, Radberg C. Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke 1991; 22: 571-576
7. Tuhrim S, Dambrosia JM, Price TR, et al. Intracerebral hemorrhage: External validation and extension of a model for prediction of 30-day survival. Ann Neurol 1991; 29: 658-663
8. Broderick JP, Brott TG, Duldner JE, et al. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24: 987-993
9. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28: 1-5
10. Flibotte JJ, Hagan N, O'Donnell J, et al. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004; 63: 1059-1064
11. Butler AB, Partain RA, Netsky MG. Primary intraventricular hemorrhage. A mild and remediable form. Neurology 1972; 22: 675-687
12. Douglas MA, Haerer AF. Long-term prognosis of hypertensive intracerebral hemorrhage. Stroke 1982; 13: 488-491
13. Daverat P, Castel JP, Dartigues JF, et al. Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke 1991; 22: 1-6
14. de Weerd AW. The prognosis of intraventricular hemorrhage. J Neurol 979; 222: 46-51
15. Young WB, Lee KP, Pessin MS, et al. Prognostic significance of ventricular blood in supratentorial hemorrhage: A volumetric study. Neurology 1990; 40: 616-619
16. Stein RW, Kase CS, Hier DB, et al. Caudate hemorrhage. Neurology 1984; 34: 1549-1554
17. Kwak R, Kadoya S, Suzuki T. Factors affecting the prognosis in thalamic hemorrhage. Stroke 1983; 14: 493-500
18. Rohde V, Schaller C, Hassler WE. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage. J Neurol Neurosurg Psychiatry 1995; 58: 447-451
19. Mayfrank L, Lippitz B, Groth M, et al. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Acta Neurochir (Wien) 1993; 122: 32-38